Regulation of peroxisome proliferator-activated receptor α by protein kinase C

Biochemistry

Volumn 44, Issue 30, 2005, Pages 10313-10321

  Gray, Joshua P ^a,c   Burns, Katherine A ^a   Leas, Tara L ^a   Perdew, Gary H ^a   Vanden Heuvel, John P ^a,b  

^a Department of Veterinary and Biomedical Sciences   (United States)

^b 325 Life Sciences Building ^*  (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CELLS; DNA; FATTY ACIDS;

HYPOLIPIDEMIC DRUGS; NUCLEAR RECEPTORS; PEROXISOME PROLIFERATORS (PP); PHOSPHOPROTEINS;

PROTEINS;

ALANINE; ANTILIPEMIC AGENT; CELL NUCLEUS RECEPTOR; FATTY ACID; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOPROTEIN; PIRINIXIC ACID; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C ZETA;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CONSENSUS SEQUENCE; COS CELLS; HUMANS; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PPAR ALPHA; PROTEIN KINASE C; PYRIMIDINES; RATS; SERINE; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; THREONINE; TRANSFECTION;

MURINAE;

EID: 23044488641     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi050721g     Document Type: Article

References (65)

1. Issemann, I., and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators [see comments], Nature 347, 645-650.
2. Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily, Science 240, 889-895.
3. Tsai, M. J., and O'Malley, B. W. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members, Annu. Rev. Biochem. 63, 451-486.
4. Green, S., and Chambon, P. (1988) Nuclear receptors enhance our understanding of transcriptional regulation, Trends Genet. 4, 309-314.
5. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., and Wahli, W. (1992) Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors, Cell 68, 879-887.
6. Miyata, K. S., Zhang, B., Marcus, S. L., Capone, J. P., and Rachubinski, R. A. (1993) Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated signaling, J. Biol. Chem. 268, 19169-19172.
7. Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene, EMBO J. 11, 433-439.
8. Gervois, P., Chopin-Delannoy, S., Fadel, A., Dubois, G., Kosykh, V., Fruchart, J. C., Najib, J., Laudet, V., and Staels, B. (1999) Fibrates increase human RJEV-ERBα expression in liver via a novel peroxisome proliferator-activated receptor response element, Mol. Endocrinol 13, 400-409.
9. Schoonjans, K., Staels, B., and Auwerx, J. (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression, J. Lipid Res. 37, 907-925.
10. Cattin, L., Da Col, P. G., Feruglio, F. S., Finazzo, L., Rimondi, S., Descovich, G., Manzato, E., Zambon, S., Crepaldi, G., Siepi, D., et al. (1990) Efficacy of ciprofibrate in primary type II and IV hyperlipidemia: The Italian multicenter study, Clin. Ther. 12, 482-488.
11. Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F. J. (1995) Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol. Cell. Biol. 15, 3012-3022.
12. Peters, J. M., Cattley, R. C., and Gonzalez, F. J. (1997) Role of PPAR α in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643, Carcinogenesis 18, 2029-2033.
13. Costet, P., Legendre, C., More, J., Edgar, A., Galtier, P., and Pineau, T. (1998) Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis, J. Biol. Chem. 273, 29577-29785.
14. Campbell, F. M., Kozak, R., Wagner, A., Altarejos, J. Y., Dyck, J. R., Belke, D. D., Severson, D. L., Kelly, D. P., and Lopaschuk, G. D. (2002) A role for peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels: Reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase, J. Biol. Chem. 277, 4098-4103.
15. Lake, B. G., Rumsby, P. C., Price, R. J., and Cunninghame, M. E. (2000) Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-β1 gene expression in the rat, Syrian hamster and guinea pig. Mutat. Res. 448, 213-225.
16. Hanefeld, M., Kemmer, C., and Kadner, E. (1983) Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man, Atherosclerosis 46, 239-246.
17. Reddy, J. K., Lalwani, N. D., Reddy, M. K., and Qureshi, S. A. (1982) Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators, Cancer Res. 42, 259-266.
18. Cattley, R. C., and Roberts, R. A. (2000) Peroxisome proliferators and carcinogenesis: Editorial perspectives, Mutat. Res. 448, 117-119.
19. Shalev, A., Siegrist-Kaiser, C. A., Yen, P. M., Wahli, W., Burger, A. G., Chin, W. W., and Meier, C. A. (1996) The peroxisome proliferator-activated receptor α is a phosphoprotein: Regulation by insulin, Endocrinology 137, 4499-4502.
20. Juge-Aubry, C. E., Hammar, E., Siegrist-Kaiser, C., Pernin, A., Takeshita, A., Chin, W. W., Burger, A. G., and Meier, C. A. (1999) Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans-activating domain. J. Biol. Chem. 274, 10505-10510.
21. Martin, G., Duez, H., Blanquart, C., Berezowski, V., Poulain, P., Fruchart, J. C., Najib-Fruchart, J., Glineur, C., and Staels, B. (2001) Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I, J. Clin. Invest. 107, 1423-1432.
22. Barger, P. M., Brandt, J. M., Leone, T. C., Weinheimer, C. J., and Kelly, D. P. (2000) Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth, J. Clin. Invest. 105, 1723-1730.
23. Vanden Heuvel, J. P. (1999) in Symposium: Steroid Hormone Receptor and Nutrient Interactions: Implications for Cancer Prevention, pp 575S-580S, American Society for Nutritional Sciences, Bethesda, MD.
24. Lazennec, G., Canaple, L., Saugy, D., and Wahli, W. (2000) Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators, Mol. Endocrinol. 14, 1962-1975.
25. Ledwith, B. J., Manam, S., Troilo, P., Joslyn, D. J., Galloway, S. M., and Nichols, W. W. (1993) Activation of immediate-early gene expression by peroxisome proliferators in vitro, Mol. Carcinog. 8, 20-27.
26. Hanley, K., Jiang, Y., He, S. S., Friedman, M., Elias, P. M., Bikle, D. D., Williams, M. L., and Feingold, K. R. (1998) Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARα, J. Invest. Dermatol. 110, 368-375.
27. Rivier, M., Safonova, I., Lebrun, P., Griffiths, C. E., Allhaud, G., and Michel, S. (1998) Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes, J. Invest. Dermatol. 111, 116-121.
28. Watanabe, T., Okawa, S., Itoga, H., Imanaka, T., and Suga, T. (1992) Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators, Biochim. Biophys. Acta 1135, 84-90.
29. Blanquart, C., Mansouri, R., Paumelle, R., Fruchart, J. C., Staels, B., and Glineur, C. (2004) The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor α, Mol. Endocrinol. 18, 1906-1918.
30. Sumanasekera, W. K., Tien, E. S., Turpey, R., Vanden Heuvel, J. P., and Perdew, G. H. (2003) Evidence that peroxisome proliferator-activated receptor α is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2, J. Biol. Chem. 278, 4467-4473.
31. Tugwood, J. D., Holden, P. R., James, N. H., Prince, R. A., and Roberts, R. A. (1998) A peroxisome proliferator-activated receptor-α (PPARα) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARα: Implications for species differences in responses to peroxisome proliferators, Arch. Toxicol. 72, 169-177.
32. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M. (1995) 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ, Cell 83, 803-812.
33. Sumanasekera, W. K., Tien, E. S., Davis, J. W., II, Turpey, R., Perdew, G. H., and Vanden Heuvel, J. P. (2003) Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARalpha) and PPARβ activity, Biochemistry 42, 10726-10735.
34. Tien, E. S., Gray, J. P., Peters, J. M., and Vanden Heuvel, J. P. (2003) Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: Identification of peroxisome proliferator-activated receptor α-dependent growth regulatory genes, Cancer Res. 63, 5767-5780.
35. Misra, P., Owuor, E. D., Li, W., Yu, S., Qi, C., Meyer, K., Zhu, Y. J., Rao, M. S., Kong, A. N., and Reddy, J. K. (2002) Phosphorylation of Transcriptional Coactivator Peroxisome Proliferator-activated Receptor (PPAR)-binding Protein (PBP). Stimulation of Transcriptional Regulation by Mitogen-Activated Protein Kinase, J. Biol. Chem. 277, 48745-48754.
36. Hunter, T., and Karin, M. (1992) The regulation of transcription by phosphorylation, Cell 70, 375-387.
37. Rochette-Egly, C. (2003) Nuclear receptors: Integration of multiple signalling pathways through phosphorylation, Cell. Signalling 15, 355-366.
38. Denton, R. R., Koszewski, N. J., and Notides, A. C. (1992) Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding, J. Biol. Chem. 267, 7263-7268.
39. Ali, S., Metzger, D., Bornert, J. M., and Chambon, P. (1993) Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region, EMBO J. 12, 1153-1160.
40. Le Goff, P., Montano, M. M., Schodin, D. J., and Katzenellenbogen, B. S. (1994) Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity, J. Biol. Chem. 269, 4458-4466.
41. Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., Curtis, S. W., Washburn, T. F., McLachlan, J. A., and Korach, K. S. (1992) Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor, Proc. Natl. Acad. Sci. U.S.A. 89, 4658-4662.
42. Arnold, S. F., Obourn, J. D., Jaffe, H., and Notides, A. C. (1995) Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro, Mol. Endocrinol. 9, 24-33.
43. Joel, P. B., Traish, A. M., and Lannigan, D. A. (1995) Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor, Mol. Endocrinol. 9, 1041-1052.
44. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase, Science 270, 1491-1494.
45. Delmotte, M. H., Tahayato, A., Formstecher, P., and Lefebvre, P. (1999) Serine 157, a retinoic acid receptor α residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARα heterodimerization and transcriptional activity, J. Biol. Chem. 274, 38225-38231.
46. Hsieh, J. C., Jurutka, P. W., Nakajima, S., Galligan, M. A., Haussler, C. A., Shimizu, Y., Shimizu, N., Whitfield, G. K., and Haussler, M. R. (1993) Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site, J. Biol. Chem. 268, 15118-15126.
47. Zhang, B., Berger, J., Zhou, G., Elbrecht, A., Biswas, S., White-Carrington, S., Szalkowski, D., and Moller, D. E. (1996) Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ, J. Biol. Chem. 271, 31771-31774.
48. Camp, H. S., Tafuri, S. R., and Leff, T. (1999) c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity, Endocrinology 140, 392-397.
49. Adams, M., Reginato, M. J., Shao, D., Lazar, M. A., and Chatterjee, V. K. (1997) Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site, J. Biol. Chem. 272, 5128-5132.
50. Reginato, M. J., Krakow, S. L., Bailey, S. T., and Lazar, M. A. (1998) Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ, J. Biol. Chem. 273, 1855-1858.
51. Hsi, L. C., Wilson, L., Nixon, J., and Eling, T. E. (2001) 15-Lipoxygenase-1 Metabolites Down-regulate Peroxisome Proliferator-activated Receptor γ via the MAPK Signaling Pathway, J. Biol. Chem. 276, 34545-34552.
52. Shao, D., Rangwala, S. M., Bailey, S. T., Krakow, S. L., Reginato, M. J., and Lazar, M. A. (1998) Interdomain communication regulating ligand binding by PPAR-γ, Nature 396, 377-380.
53. Barger, P. M., Browning, A. C., Garner, A. N., and Kelly, D. P. (2001) p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor α: A potential role in the cardiac metabolic stress response, J. Biol. Chem. 276, 44495-44501.
54. Passilly, P., Schohn, H., Jannin, B., Malki, M. C., Boscoboinik, D., Dauca, M., and Latruffe, N. (1999) Phosphorylation of peroxisome proliferator-activated receptor α in rat Fao cells and stimulation by ciprofibrate, Biochem. Pharmacol. 58, 1001-1008.
55. Rose, M. L., Germolec, D., Arteel, G. E., Schoonhoven, R., and Thurman, R. G. (1997) Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643, Chem. Res. Toxicol. 10, 1198-1204.
56. Rose, M. L., Germolec, D. R., Schoonhoven, R., and Thurman, R. G. (1997) Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators, Carcinogenesis 18, 1453-1456.
57. Bojes, H. K., and Thurman, R. G. (1994) Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo, Toxicol. Appl. Pharmacol. 126, 233-239.
58. Hijioka, T., Keller, B. J., and Thurman, R. G. (1991) Wy-14,643 but not 2-ethylhexanol increases intracellular free calcium in cultured Kupffer cells, Toxicol. Lett. 59, 239-244.
59. Bojes, H. K., and Thurman, R. G. (1996) Potent peroxisome proliferators inhibit β-oxidation in the isolated perfused rat liver, Toxicol. Appl. Pharmacol. 140, 322-327.
60. Martiny-Baron, G., Kazanietz, M. G., Mischak, H., Blumberg, P. M., Kochs, G., Hug, H., Marme, D., and Schachtele, C. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976, J. Biol. Chem. 268, 9194-9197.
61. Kashiwada, Y., Huang, L., Ballas, L. M., Jiang, J. B., Janzen, W. P., and Lee, K. H. (1994) New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C, J. Med. Chem. 37, 195-200.
62. Gschwendt, M., Muller, H. J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G., and Marks, F. (1994) Rottlerin, a novel protein kinase inhibitor, Biochem. Biophys. Res. Commun. 199, 93-98.
63. Mizukami, J., and Taniguchi, T. (1997) The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR γ and CBP, Biochem. Biophys. Res. Commun. 240, 61-64.
64. Chen, D., Pace, P. E., Coombes, R. C., and Ali, S. (1999) Phosphorylation of human estrogen receptor α by protein kinase A regulates dimerization, Mol. Cell. Biol. 19, 1002-1015.
65. Yuan, L. W., Soh, J. W., and Weinstein, I. B. (2002) Inhibition of histone acetyltransferase function of p300 by PKCδ, Biochim. Biophys. Acta 1592, 205-211.